COMMUNIQUÉS West-GlobeNewswire

Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
07/05/2026
CANTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, [...]
Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support
07/05/2026
Survey of more than 3,000 GLP‑1 patients reveals care gaps and rising out‑of‑pocket costs, underscoring employers’ need to pair flexible GLP‑1 access with ongoing lifestyle support SAN FRANCISCO, May 07, 2026 (GLOBE [...]
STERIS Appoints Pierre Boulud to Board of Directors
07/05/2026
DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. “We are [...]
LifeStance Health Group Announces Launch of Secondary Public Offering
07/05/2026
SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health [...]
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
07/05/2026
-- Topline data from randomized Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 -- -- Systemic lung cancer programs advancing with additional updates expected throughout 2026 [...]
Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
07/05/2026
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a [...]
VitalHub Announces Planned Board Succession with Appointment of Allan Brett as Chairman
07/05/2026
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today proposed changes to its Board of Directors (the “Board”) in connection with the Company’s [...]
NetraMark Announces Change To Board Of Directors
07/05/2026
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a premier artificial intelligence (AI) company transforming clinical trials [...]
Renforcement des services en santé mentale et bien-être en préparation aux situations d’urgence
07/05/2026
La Croix-Rouge canadienne lance un nouveau programme en soutien aux personnes touchées par une situation d’urgence au pays OTTAWA, Ontario, 07 mai 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne annonce le lancement [...]
Strengthening Mental Health and Psychosocial Support Preparedness in Emergencies
07/05/2026
Canadian Red Cross launches new program to support Canadians impacted by emergencies OTTAWA, Ontario, May 07, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross has announced the Strengthening Mental Health and [...]
Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting
07/05/2026
Data show promising and sustained improvements across key measures of visual function, including low luminance visual acuity and mean macular sensitivity as measured by microperimetry. Laru-zova was generally well- [...]
INVIAH Launches Beta in Chicago: The Doctor Comes to You
07/05/2026
Co-founders Dr. Yevhen Pavelko and Natallia Panysh introduce a physician home-visit platform, powered by proprietary AI technology, that addresses systemic failures in U.S. healthcare access, bringing in-person medical [...]
Serotonin Centers Highlights 5-Day Live Training Program as Cornerstone of Franchise Support and Performance
07/05/2026
Proven, Hands-On Training Model Drives Consistency, Team Confidence, and Client Outcomes Across National Footprint ORLANDO, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Serotonin Centers, a national leader in science-backed [...]
BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease
07/05/2026
Oral presentation at ISCT 2026 included larger 52-week follow-up cohort, with 52% of evaluable patients achieving at least 50% improvement in both VAS pain and ODI function measures and no dose-limiting toxicity safety [...]
SK pharmteco collabore avec Axle Informatics et les Instituts nationaux de la santé afin de développer des programmes de thérapie génique pour les maladies rares
07/05/2026
RANCHO CORDOVA, Californie, 07 mai 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé ce jour un partenariat stratégique avec Axle Informatics et les Instituts nationaux de la santé (NIH) en vue de promouvoir le [...]
The Helios Alliance Applauds Dr. Rahul Gupta's Appointment to Knoa Foundation Board of Trustees
07/05/2026
Leadership team member brings national expertise to oversight of pharmaceutical company emerging from Purdue Pharma settlement, advancing transparency and accountability in opioid abatement nationwide Mobile, ALABAMA, [...]
TOMI Environmental Solutions’ Binary Ionization Technology Approved in Additional European Union Countries
07/05/2026
FREDERICK, Md., May 07, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that its Binary Ionization [...]
Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
07/05/2026
Submission supports advancement of a long‑term, fully implantable, blood‑based continuous glucose monitoring platform RUTHERFORD, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or [...]
Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute
07/05/2026
First patient ever treated with Alpha DaRT for pancreatic cancer in Italy, under a clinical study conducted at the world-renowned Pancreas Institute of the University of Verona The study is the first Alpha DaRT [...]

Pages